| Author | 杉浦 裕子| 曽我 賢彦| 前田 嘉信| |
|---|---|
| Published Date | 2010-09-01 |
| Publication Title | 造血細胞移植now&future |
| Volume | volume20 |
| Content Type | Article |
| Title Alternative | Molecular targeted therapies in leukemia |
|---|---|
| FullText URL | 126_49.pdf |
| Author | Maeda, Yoshinobu| Tanimoto, Mitsune| |
| Keywords | 白血病 分子標的薬 チロシンキナーゼ阻害薬 |
| Publication Title | 岡山医学会雑誌 |
| Published Date | 2014-04-01 |
| Volume | volume126 |
| Issue | issue1 |
| Start Page | 49 |
| End Page | 54 |
| ISSN | 0030-1558 |
| Related Url | http://www.okayama-u.ac.jp/user/oma/ |
| language | Japanese |
| Copyright Holders | Copyright (c) 2014 岡山医学会 |
| File Version | publisher |
| DOI | 10.4044/joma.126.49 |
| Title Alternative | An investigator initiated phase II clinical trial of tamibarotene (AM80G) for chronic graft-versus-host disease |
|---|---|
| FullText URL | 127_133.pdf |
| Author | Nishimori, Hisakazu| Maeda, Yoshinobu| |
| Keywords | 臨床研究中核病院 慢性GVHD タミバロテン 同種造血幹細胞移植 Th17 |
| Publication Title | 岡山医学会雑誌 |
| Published Date | 2015-08-03 |
| Volume | volume127 |
| Issue | issue2 |
| Start Page | 133 |
| End Page | 137 |
| ISSN | 0030-1558 |
| Related Url | isVersionOf https://doi.org/10.4044/joma.127.133 |
| language | Japanese |
| Copyright Holders | Copyright (c) 2015 岡山医学会 |
| File Version | publisher |
| DOI | 10.4044/joma.127.133 |
| NAID | 130005096255 |
| Author | Asakura, Shoji| Hashimoto, Daigo| Takashima, Shuichiro| Sugiyama, Haruko| Maeda, Yoshinobu| Akashi, Koichi| Tanimoto, Mitsune| Teshima, Takanori| |
|---|---|
| Published Date | 2012-04-01 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume124 |
| Issue | issue1 |
| Content Type | Journal Article |
| Title Alternative | Kibichuo Town is the first National Strategic Special Zone for innovative business collaboration in Japan: The role of universities in achieving regulatory reform with a vision toward a Digital Garden City Nation |
|---|---|
| Author | Nasu, Yasutomo| Maki, Jota| Sakurai, Jun| Masuyama, Hisashi| Maeda, Yoshinobu| |
| Publication Title | Journal of Okayama Medical Association |
| Published Date | 2022-08-01 |
| Volume | volume134 |
| Issue | issue2 |
| Start Page | 115 |
| End Page | 118 |
| ISSN | 0030-1558 |
| Related Url | isVersionOf https://doi.org/10.4044/joma.134.115 |
| language | Japanese |
| Copyright Holders | Copyright (c) 2022 岡山医学会 |
| File Version | publisher |
| DOI | 10.4044/joma.134.115 |
| Author | Nishimori, Hisakazu| Maeda, Yoshinobu| Tanimoto, Mitsune| |
|---|---|
| Published Date | 2012-12-03 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume124 |
| Issue | issue3 |
| Content Type | Journal Article |
| Author | Takata, Katsuyoshi| Sato, Yasuharu| Nakamura, Naoya| Tokunaka, Mami| Miki, Yukari| Kikuti, Yara Yukie| Igarashi, Kazuhiko| Ito, Etsuro| Harigae, Hideo| Kato, Seiichi| Hayashi, Eiko| Oka, Takashi| Hoshii, Yoshinobu| Tari, Akira| Okada, Hiroyuki| Mohamado, ABD Alkader Lamia| Maeda, Yoshinobu| Tanimoto, Mitsune| Kinoshita, Tomohiro| Yoshino, Tadashi| |
|---|---|
| Published Date | 2013-08-01 |
| Publication Title | 岡山医学会雑誌 |
| Volume | volume125 |
| Issue | issue2 |
| Content Type | Journal Article |
| Title Alternative | Molecular targeted therapy in myeloma and lymphoma |
|---|---|
| FullText URL | 126_143.pdf |
| Author | Saeki, Kyosuke| Maeda, Yoshinobu| Tanimoto, Mitsune| |
| Keywords | 骨髄腫 リンパ腫 分子標的治療薬 |
| Publication Title | 岡山医学会雑誌 |
| Published Date | 2014-08-01 |
| Volume | volume126 |
| Issue | issue2 |
| Start Page | 143 |
| End Page | 150 |
| ISSN | 0030-1558 |
| language | Japanese |
| Copyright Holders | Copyright (c) 2014 岡山医学会 |
| File Version | publisher |
| DOI | 10.4044/joma.126.143 |
| NAID | 130004685266 |
| JaLCDOI | 10.18926/AMO/61429 |
|---|---|
| FullText URL | 75_1_15.pdf |
| Author | Katsui, Kuniaki| Ogata, Takeshi| Tada, Akihiro| Sugiyama, Soichi| Yoshio, Kotaro| Kuroda, Masahiro| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Hiraki, Takao| Kanazawa, Susumu| |
| Abstract | The aim of this study was to investigate whether volumetric positron emission tomography (PET) parameters are prognostic predictors in stage III non-small cell lung cancer patients receiving definitive concurrent chemo-radiotherapy (CCRT) with cisplatin/docetaxel. Cases involving definitive CCRT were reviewed retrospectively, and the maximum standardized uptake value, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were calculated. The relationships between these PET parameters and prognosis were analyzed. MTV and TLG were significant predictors of distant metastasis-free survival (DMFS) (p = 0.0003 and 0.0005, respectively) and progression-free survival (PFS) (p = 0.001 and 0.0007, respectively). The three-year DMFS rates in patients with low and high MTV were 13.3% and 64.6%, respectively, and the corresponding values in those with low and high TLG were 13.3% and 65.2%, respectively. The three-year PFS rates in patients with low and high MTV were 13.3% and 57.8%, respectively, and the corresponding values in patients with low and high TLG were 13.3% and 57.8%, respectively. However, MTV and TLG were not predictors of local control or overall sur-vival. We demonstrated that volumetric PET parameters were predictors of patients receiving definitive CCRT. Our findings contradict the findings of previous reports and warrant further research to validate them. |
| Keywords | volumetric positron emission tomography parameters distant metastasis-free survival chemoradiotherapy cisplatin/docetaxel non-small cell lung cancer |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2021-02 |
| Volume | volume75 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 15 |
| End Page | 23 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2021 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 33649609 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Watanabe, Hiromi| Ichihara, Eiki| Kayatani, Hiroe| Makimoto, Go| Ninomiya, Kiichiro| Nishii, Kazuya| Higo, Hisao| Ando, Chihiro| Okawa, Sachi| Nakasuka, Takamasa| Kano, Hirohisa| Hara, Naofumi| Hirabae, Atsuko| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Rai, Kammei| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| Published Date | 2021-01-07 |
| Publication Title | Cancer science |
| Publisher | Wiley |
| ISSN | 1347-9032 |
| NCID | AA11808050 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2021 The Authors. |
| File Version | publisher |
| PubMed ID | 33410241 |
| NAID | 120007008532 |
| DOI | 10.1111/cas.14801 |
| Web of Science KeyUT | 000630136900001 |
| Related Url | isVersionOf https://doi.org/10.1111/cas.14801 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Kano, Hirohisa| Ichihara, Eiki| Harada, Daijiro| Inoue, Koji| Kayatani, Hiroe| Hosokawa, Shinobu| Kishino, Daizo| Watanabe, Kazuhiko| Ochi, Nobuaki| Oda, Naohiro| Hara, Naofumi| Ninomiya, Kiichiro| Hotta, Katsuyuki| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| Keywords | immune checkpoint inhibitor non-small cell-lung cancer PD-L1 pembrolizumab poor performance status |
| Published Date | 2020-07-29 |
| Publication Title | Cancer Science |
| Volume | volume111 |
| Issue | issue10 |
| Publisher | Wiley |
| Start Page | 3739 |
| End Page | 3746 |
| ISSN | 1347-9032 |
| NCID | AA11808050 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2020 The Authors. |
| File Version | publisher |
| PubMed ID | 32726470 |
| DOI | 10.1111/cas.14590 |
| Web of Science KeyUT | 000562490200001 |
| Related Url | isVersionOf https://doi.org/10.1111/cas.14590 |
| FullText URL | fulltext20210601-2.pdf |
|---|---|
| Author | Muro, Misato| Soga, Yoshihiko| Higuchi, Tomoko| Kataoka, Kota| Ekuni, Daisuke| Maeda, Yoshinobu| Morita, Manabu| |
| Keywords | hematopoietic stem cell transplantation oral mucositis microbiota antibiotics PCR-denaturing gradient gel electrophoresis |
| Note | This is a post-peer-review, pre-copyedit version of an article published in Folia Microbiologica. The final authenticated version is available online at: http://dx.doi.org/10.1007/s12223-018-0596-1.| |
| Published Date | 2018-03-12 |
| Publication Title | Folia Microbiologica |
| Volume | volume63 |
| Issue | issue5 |
| Publisher | Springer Science and Business Media LLC |
| Start Page | 587 |
| End Page | 597 |
| ISSN | 0015-5632 |
| NCID | AA00648779 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| File Version | author |
| PubMed ID | 29532421 |
| NAID | 120007042396 |
| DOI | 10.1007/s12223-018-0596-1 |
| Web of Science KeyUT | 000440115900006 |
| Related Url | isVersionOf https://doi.org/10.1007/s12223-018-0596-1 |
| FullText URL | fulltext20210810-3.pdf |
|---|---|
| Author | Nishii, Kazuya| Ohashi, Kadoaki| Watanabe, Hiromi| Makimoto, Go| Nakasuka, Takamasa| Higo, Hisao| Ninomiya, Kiichiro| Kato, Yuka| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| Keywords | epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α |
| Published Date | 2021-7-7 |
| Publication Title | Oncology Letters |
| Volume | volume22 |
| Issue | issue3 |
| Publisher | Spandidos Publications |
| Start Page | 639 |
| ISSN | 1792-1074 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License. |
| File Version | publisher |
| DOI | 10.3892/ol.2021.12900 |
| Web of Science KeyUT | 000678494600001 |
| Related Url | isVersionOf https://doi.org/10.3892/ol.2021.12900 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Kitamura, Wataru| Asada, Noboru| Tabata, Tetsuya| Shibata, Rei| Nishi, Tatsuya| Kato, Yuka| Takasuka, Hiroki| Fujiwara, Hideaki| Ennishi, Daisuke| Nishimori, Hisakazu| Fujii, Nobuharu| Matsuoka, Ken-Ichi| Kiura, Katsuyuki| Yoshino, Tadashi| Maeda, Yoshinobu| |
| Keywords | marginal zone lymphoma diffuse large B-cell lymphoma anterior mediastinum cystic lesions |
| Published Date | 2022 |
| Publication Title | Journal Of Clinical And Experimental Hematopatholo |
| Volume | volume62 |
| Issue | issue1 |
| Publisher | The Japanese Society for Lymphoreticular Tissue Research |
| Start Page | 35 |
| End Page | 40 |
| ISSN | 1346-4280 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2021 The Japanese Society for Lymphoreticular Tissue Research |
| File Version | publisher |
| PubMed ID | 34840205 |
| DOI | 10.3960/jslrt.21010 |
| Web of Science KeyUT | 000766876600003 |
| Related Url | isVersionOf https://doi.org/10.3960/jslrt.21010 |
| JaLCDOI | 10.18926/AMO/66912 |
|---|---|
| FullText URL | 78_2_095.pdf |
| Author | Itano, Junko| Kiura, Katsuyuki| Maeda, Yoshinobu| Miyahara, Nobuaki| |
| Abstract | The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases. |
| Keywords | neuropeptide y Y1 receptor airway immune response bronchial epithelial cells respiratory disease |
| Amo Type | Review |
| Publication Title | Acta Medica Okayama |
| Published Date | 2024-04 |
| Volume | volume78 |
| Issue | issue2 |
| Publisher | Okayama University Medical School |
| Start Page | 95 |
| End Page | 106 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | Copyright Ⓒ 2024 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Nishimura, Tomoka| Ichihara, Eiki| Yokoyama, Toshihide| Inoue, Koji| Tamura, Tomoki| Sato, Ken| Oda, Naohiro| Kano, Hirohisa| Kishino, Daizo| Kawai, Haruyuki| Inoue, Masaaki| Ochi, Nobuaki| Fujimoto, Nobukazu| Ichikawa, Hirohisa| Ando, Chihiro| Hotta, Katsuyuki| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| Keywords | pleural effusion non-small cell carcinoma immune checkpoint inhibitors |
| Published Date | 2022-12-14 |
| Publication Title | Cancers |
| Volume | volume14 |
| Issue | issue24 |
| Publisher | MDPI |
| Start Page | 6184 |
| ISSN | 2072-6694 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2022 by the authors. |
| File Version | publisher |
| PubMed ID | 36551668 |
| DOI | 10.3390/cancers14246184 |
| Web of Science KeyUT | 000900618600001 |
| Related Url | isVersionOf https://doi.org/10.3390/cancers14246184 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Higo, Hisao| Ichikawa, Hirohisa| Arakawa, Yukako| Mori, Yoshihiro| Itano, Junko| Taniguchi, Akihiko| Senoo, Satoru| Kimura, Goro| Tanimoto, Yasushi| Miyake, Kohei| Katsuta, Tomoya| Kataoka, Mikio| Maeda, Yoshinobu| Kiura, Katsuyuki| Miyahara, Nobuaki| Okayama Respiratory Disease Study Group (ORDSG)| |
| Keywords | dupilumab severe asthma treatment interval eosinophilic chronic rhinosinusitis |
| Published Date | 2023-08-09 |
| Publication Title | Journal of Clinical Medicine |
| Volume | volume12 |
| Issue | issue16 |
| Publisher | MDPI |
| Start Page | 5174 |
| ISSN | 2077-0383 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2023 by the authors. |
| File Version | publisher |
| PubMed ID | 37629217 |
| DOI | 10.3390/jcm12165174 |
| Web of Science KeyUT | 001056259200001 |
| Related Url | isVersionOf https://doi.org/10.3390/jcm12165174 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Kobayashi, Hiroki| Ouchi, Tomoki| Kitamura, Wataru| Asakura, Shoji| Yano, Tomofumi| Takeda, Hiromasa| Tokuda, Yoshiyuki| Yoshino, Tadashi| Maeda, Yoshinobu| |
| Keywords | cold agglutinin disease severe acute respiratory syndrome coronavirus 2 sutimlimab |
| Published Date | 2023-12-26 |
| Publication Title | Journal of Clinical and Experimental Hematopathology |
| Volume | volume63 |
| Issue | issue4 |
| Publisher | The Japanese Society for Lymphoreticular Tissue Research |
| Start Page | 246 |
| End Page | 250 |
| ISSN | 1346-4280 |
| NCID | AA11556796 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2023 The Japanese Society for Lymphoreticular Tissue Research |
| File Version | publisher |
| PubMed ID | 38148014 |
| DOI | 10.3960/jslrt.23040 |
| Web of Science KeyUT | 001134578000003 |
| Related Url | isVersionOf https://doi.org/10.3960/jslrt.23040 |
| FullText URL | fulltext.pdf |
|---|---|
| Author | Makimoto, Go| Shimonishi, Atsushi| Ohashi, Kadoaki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
| Keywords | MET Tepotinib Non-small-cell lung cancer |
| Published Date | 2022 |
| Publication Title | Case Reports In Oncology |
| Volume | volume15 |
| Issue | issue2 |
| Publisher | Karger |
| Start Page | 494 |
| End Page | 498 |
| ISSN | 1662-6575 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | © 2022 The Author(s). |
| File Version | publisher |
| PubMed ID | 35702678 |
| DOI | 10.1159/000524326 |
| Web of Science KeyUT | 000864085100005 |
| Related Url | isVersionOf https://doi.org/10.1159/000524326 |
| JaLCDOI | 10.18926/AMO/61904 |
|---|---|
| FullText URL | 75_2_219.pdf |
| Author | Sugiura, Hiroyuki| Nishimori, Hisakazu| Matsuoka, Hirofumi| Nakamura, Keiichiro| Fujii, Keiko| Fujii, Nobuharu | Matsuoka, Ken-ichi | Maeda, Yoshinobu| |
| Abstract | Acute promyelocytic leukemia (APL) is a hematological emergency that requires urgent intervention because of the high incidence of early hemorrhagic death. When patients with APL experience a synchronous solid organ tumor, the tumor’s treatment must also be done properly. Differentiation-inducing therapy using arsenic trioxide (ATO) has less hematological toxicity compared to cytotoxic chemotherapy and might be preferable for untreated APL patients with a synchronous solid organ tumor. Here we describe the first successful case of untreated APL and synchronous endometrial cancer (in an adult Japanese woman) treated with ATO consolidation therapy and the subsequent surgery and chemotherapy for endometrial cancer. |
| Keywords | acute promyelocytic leukemia endometrial cancer arsenic trioxide synchronous multiple primary malignant tumor chemotherapy |
| Amo Type | Case Report |
| Publication Title | Acta Medica Okayama |
| Published Date | 2021-04 |
| Volume | volume75 |
| Issue | issue2 |
| Publisher | Okayama University Medical School |
| Start Page | 219 |
| End Page | 224 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2021 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 33953429 |
| NAID | 120007029883 |
